Compliance with group B streptococcal disease prevention guidelines

MCN The American Journal of Maternal Child Nursing

Volumn 26, Issue 6, 2001, Pages 313-319

  Chandran, Latha ^a   Navaie Waliser, Maryam ^a   Zulqarni, Naz J ^a   Batra, Sandeep ^a   Bayir, Hulya ^a   Shah, Michelle ^a   Lincoln, Priscilla P ^a  

^a NONE

Author keywords

Infant; Practice Guidelines; Pregnancy; Streptococcus Group B

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; FEMALE; HUMAN; NEWBORN; NONPARAMETRIC TEST; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

DISEASE TRANSMISSION, VERTICAL; FEMALE; GUIDELINE ADHERENCE; HUMAN; INFANT, NEWBORN; NEW YORK; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0035514616     PISSN: 0361929X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005721-200111000-00008     Document Type: Article

References (22)

1. Baker, C. J., & Edwards, M. S. (1995). Group B Streptococcal infections. In J. Remington & J. O. Klein (Eds.), Infectious Diseases of the Fetus and Newborn (4th ed.), (pp. 980-1054). Philadelphia: WB Saunders Co.
2. Boyer, K. M., & Gotoff, S. P. (1998). Alternative algorithms for prevention of perinatal Group B Streptococcal infections. Pediatric Infectious Disease Journal, 17, 973-979.
3. Centers for Disease Control and Prevention (CDC). (1996). Prevention of perinatal Group B Streptococcal disease: A public health perspective. Morbidity and Mortality Weekly Report (MMWR), 45, 1-24.
4. Centers for Disease Control and Prevention (CDC). (1997). Decreasing incidence of perinatal Group B Streptococcal disease - United States, 1993-1995. Morbidity and Mortality Weekly Report, 46, 473-477.
5. Centers for Disease Control and Prevention (CDC). (1998). Adoption of hospital policies for prevention of perinatal Group B Streptococcal disease -United States, 1997. Morbidity and Mortality Weekly Report, 47, 65-70.
6. Cheon-Lee, E., & Amstey, M. S. (1998). Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing Group B Streptococcal neonatal sepsis. American Journal of Obstetrics and Gynecology, 179, 77-79.
7. Committee on Infectious Diseases and Committee on Fetus and Newborn (CIDFNAP). (1992). American Academy of Pediatrics. Guidelines for prevention of Group B Streptococcal (GBS) infection by chemoprophylaxis. Pediatrics, 90, 775-778.
8. Committee on Infectious Diseases and Committee on Fetus and Newborn (CIDFNAP). American Academy of Pediatrics. (1997). Revised guidelines for prevention of early onset Group B Streptococcal infection. Pediatrics, 99, 489-496.
9. Gibbs, R. S., McDuffie, R. S. Jr, McNabb, F., Fryer, G. E., Miyoshi, T., & Merenstein, G. (1994). Neonatal Group B Streptococcal sepsis during 2 years of a universal screening program. Obstetrics and Gynecology, 84, 496-500.
10. Gotoff, S. P., & Boyer, K. M. (1997). Prevention of early-onset neonatal Group B Streptococcal disease. Pediatrics, 99, 866-868.
11. Kowalski, K., MacMullen, N., Stifter, J., Brundage, J., Slack, J.F., Strodtbeck, F., et al. (1996). The high-touch paradigm: A 21st century model for maternal child nursing. With a brief glimpse into nursing on the starship Nightingale. MCN, The American Journal of Maternal/Child Nursing, 21, 43-50.
12. Lieu, T. A., Moehle-Botani, J. C., Ray, G. T., Ackerson, L. M., & Walton, D. L. (1998). Neonatal Group B Streptococcal infection in a managed care population. Perinatal Group B Streptococcal Infection Study Group. Obstetrics and Gynecology, 92, 21-27.
13. McDuffie, R. S. Jr, McGregor, J. A., & Gibbs, R. S. (1993). Adverse perinatal outcome and resistant Enterobacteriaciae after antibiotic usage for premature rupture of membranes and Group B Streptococcus carriage. Obstetrics and Gynecology, 82, 487-489.
14. Mercer, B. M., Ramsey, R. D., & Sibai, B. M. (1995). Prenatal screening for Group B Streptococcus II. Impact of antepartum screening and prophylaxis on neonatal care. American Journal of Obstetrics and Gynecology, 173, 842-846.
15. Peralta-Carcelen, M., Faragasson, C. A. Jr, Cliver, S. P., Cutter, G. R., Gigante, J., & Goldenberg, R. L. (1996). Impact of maternal Group B Streptococcal screening in pediatric management in full-term new-borns. Archives of Pediatric and Adolescent Medicine, 150, 802-808.
16. Rosenstein, N. E., & Schuchat, A. (1997). Opportunities for prevention of perinatal Group B Streptococcal disease: A multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstetrics and Gynecology, 90, 901-906.
17. Rouse, D. J., Goldenberg, R. L., Cliver, S. P., Cutter, G. R., Mennemeyer, S. T., & Fragason, C. A. (1994). Strategies for prevention of early-onset neonatal Group B Streptococcal sepsis: A decision analysis. Obstetrics and Gynecology, 83, 483-494.
18. Statistical Analysis System. (1996). 6.12 ed. Cary, NC: The SAS Institute.
19. Schuchat, A., Deaver-Robinson, K., & Plikaytis, B. (1994). Multistate case control study of maternal risk factors for neonatal Group B Streptococcal disease. Pediatric Infectious Disease Journal, 13, 623-629.
20. Towers, C.V., Carr, M. H., Padilla, G., & Asrat, T. (1998). Potential consequences of widespread antepartal use of ampicillin. American Journal of Obstetrics and Gynecology, 84, 496-500.
21. Whitney, C. G., Plikaytis, B. D., Gozansky, W. S., Wenger, J. D., & Shuchat, A. (1997). Prevention practices for perinatal Group B Streptococcal disease: A multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Prevention Group. Obstetrics and Gynecology, 89, 28-32.
22. Zangwill, K. M., Schuchat, A., & Wenger, J. D. (1992). Group B Streptococcal Disease in the United States, 1990: Report from a multi-state active surveillance system. Morbidity and Mortality Weekly Report, 41(No. SS-6), 25-32.